Tag: DIAL
ASN: Ellipsys Percutaneous Fistula Durable for Hemodialysis Access
High rate of fistula use, low rates of secondary procedures and complications seen at five years
For Dialysis Recipients, Antibody Response Lowest With Ad26.COV2.S
Patients receiving attenuated adenovirus vaccine more likely to have no seroconversion, no detectable or diminished IgG response
Hemodialysis Patients Have Antibody Response to COVID-19 Vaccine
But few kidney transplant recipients develop anti-spike SARS-CoV-2 antibodies after second mRNA vaccine dose
Factors ID’d for COVID-19 Infection Risk in Dialysis Patients
Age, diabetes, local community COVID-19 rates, dialysis unit size linked to positive test for infection or admission with suspected COVID-19
Erythropoietin May Up Risk for Hip Fracture in Hemodialysis Patients
Risk for hip fracture increased with EPO doses of 50 to 149, 150 to 299, and ≥300 versus <50 units/kg/week
COVID-19 Vaccine Hesitancy Found for 20 Percent on Hemodialysis
Increased odds of vaccine hesitancy seen for patients aged 18 to 44 years, Black and Native Americans or Pacific Islanders, women
COVID-19 Case Fatality Rate High in Long-Term Dialysis Patients
Racial, sociodemographic, and dialysis-related factors predict COVID-19 infection risk among long-term dialysis patients
Many Dialysis Patients Report Proficiency in Mobile Health
Older patients have lower mobile health proficiency, as do those with Hispanic/Latinx ethnicity, less than college education
Intradialytic Hypotension Tied to Peripheral Artery Disease
Findings based on large, national study of more than 45,000 hemodialysis patients
More Long-Term Dialysis Patients Aligned to ACOs
Among Medicare beneficiaries on dialysis, less spent per beneficiary-quarter for ACO-aligned versus nonaligned